EyePoint Pharmaceuticals Inc
NASDAQ:EYPT 1:42:00 PM EDT
| Market Cap (Intraday) | 292.15M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $9.41 |
| 50-Day MA | $13.27 |
| 200-Day MA | $10.89 |
EyePoint Pharmaceuticals Inc Stock, NASDAQ:EYPT
480 Pleasant Street, Suite B300, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.926.5000
Number of Employees: 101
Description
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.